CSIMarket
 


Fulgent Genetics Inc   (FLGT)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

FLGT's Operating Income Growth by Quarter and Year

Fulgent Genetics Inc 's Operating Income results by quarter and year




FLGT Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -36.55 150.86 225.91
III Quarter September 0.21 0.35 159.27 63.52
II Quarter June -19.80 12.79 98.90 2.64
I Quarter March -24.82 201.93 266.92 -1.91
FY   -44.41 178.52 675.95 290.16



FLGT Operating Income third quarter 2023 Y/Y Growth Comment
Fulgent Genetics Inc reported fall in Operating Income in the third quarter 2023 by -38.86% to $ 0.21 millions, from the same quarter in 2022.
The drop in the third quarter 2023 Fulgent Genetics Inc 's Operating Income compares unfavorably to the Company's average Operating Income doubling of 935.31%.

Looking into third quarter 2023 results within Medical Laboratories industry 9 other companies have achieved higher Operating Income growth. While Fulgent Genetics Inc ' s Operating Income drop of -38.86% ranks overall at the positon no. 1798 in the third quarter 2023.

Explain Operating Income growth


FLGT Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - -33.22 % -
III Quarter September -38.86 % -99.78 % 150.74 % 4106.62 %
II Quarter June - -87.07 % 3646.21 % 780 %
I Quarter March - -24.35 % - -
FY   - -73.59 % 132.96 % -

Financial Statements
Fulgent Genetics Inc 's third quarter 2023 Operating Income $ 0.21 millions FLGT's Income Statement
Fulgent Genetics Inc 's third quarter 2022 Operating Income $ 0.35 millions Quarterly FLGT's Income Statement
New: More FLGT's historic Operating Income Growth >>


FLGT Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - -5.28 % 255.65 %
III Quarter September - -97.26 % 61.04 % 2306.06 %
II Quarter June - -93.67 % -62.95 % -
I Quarter March - 33.85 % 18.15 % -
FY (Year on Year)   - -73.59 % 132.96 % -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #120
Overall #1798

Operating Income Y/Y Growth Statistics
High Average Low
4109.61 % 935.31 % -99.78 %
(Sep 30 2020)   (Sep 30 2022)
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #10
Healthcare Sector #120
Overall #1798
Operating Income Y/Y Growth Statistics
High Average Low
4109.61 % 935.31 % -99.78 %
(Sep 30 2020)   (Sep 30 2022)

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Fulgent Genetics Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FLGT's III. Quarter Q/Q Operating Income Comment
Improvement III. Quarter 2023where Fulgent Genetics Inc posted Operating Income of $ 0.21 millions could be considered as a starting point of better performance.Fulgent Genetics Inc announced in the III. Quarter 2023 Operating Income of $ 0.21 millions compare to Operating Loss recorded in previos quarter.

Within Medical Laboratories industry Fulgent Genetics Inc achieved highest sequential Operating Income growth. While Fulgent Genetics Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FLGT's III. Quarter Q/Q Operating Income Comment
This turnaround III. Quarter 2023where Fulgent Genetics Inc delivered Operating Income of $ 0.21 millions should is starting point of positive performance.Fulgent Genetics Inc announced in the III. Quarter 2023 Operating Income of $ 0.21 millions compare to Operating Loss recorded in previos quarter.

Within Medical Laboratories industry Fulgent Genetics Inc achieved highest sequential Operating Income growth. While Fulgent Genetics Inc 's Operating Income growth quarter on quarter, overall rank is .


Fulgent Genetics Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -80.96 $ -80.82 $ -48.23 $ 178.53 $ 365.94
Y / Y Operating Income Growth (TTM) - - - -73.59 % -51.27 %
Year on Year Operating Income Growth Overall Ranking # 1015 # 1411 # 981 # 182 # 1731
Seqeuential Operating Income Change (TTM) - - - -51.21 % -30.28 %
Seq. Operating Income Growth (TTM) Overall Ranking # 918 # 1313 # 1402 # 1510 # 2049




Cumulative Operating Income growth Comment
Fulgent Genetics Inc realized trailing twelve months Operating Loss of $ -81 millions, in the Sep 30 2023, compare to Operating Income of $ 366 millions a year ago.

In the Healthcare sector 63 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1015, from total ranking in previous quarter at 1411.

Operating Income TTM Q/Q Growth Statistics
High Average Low
35784.56 %
2421.47 %
-9876.81 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 64
Overall # 1015

Operating Income TTM Y/Y Growth Statistics
High Average Low
35784.56 %
2421.47 %
-9876.81 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 55
S&P 500 # 918
Cumulative Operating Income growth Comment
Fulgent Genetics Inc realized trailing twelve months Operating Loss of $ -81 millions, in the Sep 30 2023, compare to Operating Income of $ 366 millions a year ago.

In the Healthcare sector 63 other companies have achieved higher trailing twelve month Operating Income growth. While Total ranking has impoved so far to 1015, from total ranking in previous quarter at 1411.

Operating Income TTM Q/Q Growth Statistics
High Average Low
35784.56 %
2421.47 %
-9876.81 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 3
Healthcare Sector # 64
Overall # 1015

Operating Income TTM Y/Y Growth Statistics
High Average Low
35784.56 %
2421.47 %
-9876.81 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 55
S&P 500 # 918




Other Operating Income Growth
Medical Laboratories Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
FLGT's Operating Income Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for FLGT's Competitors
Operating Income Growth for Fulgent Genetics Inc 's Suppliers
Operating Income Growth for FLGT's Customers

You may also want to know
FLGT's Annual Growth Rates FLGT's Profitability Ratios FLGT's Asset Turnover Ratio FLGT's Dividend Growth
FLGT's Roe FLGT's Valuation Ratios FLGT's Financial Strength Ratios FLGT's Dividend Payout Ratio
FLGT's Roa FLGT's Inventory Turnover Ratio FLGT's Growth Rates FLGT's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Bio techne Corp-0.81%$ -0.808 millions
The Pennant Group Inc -1.16%$ -1.162 millions
Bio rad Laboratories Inc -1.99%$ -1.990 millions
Corcept Therapeutics Inc-2.37%$ -2.371 millions
Mettler toledo International Inc -3.07%$ -3.068 millions
Tenet Healthcare Corp-4.70%$ -4.698 millions
West Pharmaceutical Services Inc -4.78%$ -4.780 millions
Bruker Corporation-5.18%$ -5.179 millions
Henry Schein Inc-5.21%$ -5.213 millions
Hologic Inc-5.96%$ -5.962 millions
Sonida Senior Living Inc -6.27%$ -6.269 millions
Abbott Laboratories-6.95%$ -6.949 millions
Gilead Sciences Inc -7.54%$ -7.543 millions
Vertex Pharmaceuticals Inc-7.86%$ -7.864 millions
Bristol myers Squibb Company-9.18%$ -9.183 millions
Regeneron Pharmaceuticals Inc -9.21%$ -9.210 millions
National Research Corporation-10.39%$ -10.388 millions
Quest Diagnostics Inc-12.76%$ -12.755 millions
Bausch and Lomb Corp-13.04%$ -13.043 millions
Carlisle Companies Incorporated-13.87%$ -13.871 millions
Pediatrix Medical Group Inc -15.01%$ -15.015 millions
Community Health Systems Inc -15.20%$ -15.196 millions
Teva Pharmaceutical Industries Limited-15.27%$ -15.274 millions
Zynex inc -16.36%$ -16.362 millions
Entera Bio Ltd -16.72%$ -16.719 millions
Pacira Biosciences inc -16.76%$ -16.760 millions
Viatris Inc -19.35%$ -19.354 millions
Royalty Pharma Plc-21.21%$ -21.210 millions
Luna Innovations Inc-22.06%$ -22.057 millions
Avantor Inc -23.79%$ -23.785 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com